These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1808269)

  • 1. [Anticoagulation].
    Matsuda O
    Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis.
    Matsui N; Nakagawa S; Sasaoka T; Suenaga M; Yoshiyama N; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1979; 16():135-40. PubMed ID: 121458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
    Pinnick RV; Wiegmann TB; Diederich DA
    N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in platelets, coagulation and fibrinolysis in patients with chronic kidney diseases and hemodialysis].
    Terada H
    Nihon Rinsho; 1992 Jan; 50 Suppl():565-72. PubMed ID: 1578739
    [No Abstract]   [Full Text] [Related]  

  • 6. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.
    Mottaghy K; Oedekoven B; Bey R; Schmid-Schönbein H
    Trans Am Soc Artif Intern Organs; 1985; 31():534-6. PubMed ID: 3939276
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional citrate anticoagulation in chronic hemodialysis patients.
    Seaton RD; Duncan KA; Pinnick RV; Diederich DA; Wiegmann TB
    Trans Am Soc Artif Intern Organs; 1983; 29():414-8. PubMed ID: 6673262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation for plasmapheresis].
    Amemiya H; Sekihara H; Kobayashi T; Koiwa F; Niikura K
    Nihon Rinsho; 2004 May; 62 Suppl 5():323-7. PubMed ID: 15197938
    [No Abstract]   [Full Text] [Related]  

  • 10. Review: anticoagulation for haemodialysis.
    Suranyi M; Chow JS
    Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of temperature upon the heparin and citrate clotting times.
    LOSNER S; VOLK BW
    Am J Med Sci; 1953 Jul; 226(1):60-4. PubMed ID: 13065283
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodialysis with a Permcath kept open with streptokinase and later citrate in a heparin-sensitive patient.
    Purchase L; Gault MH
    Nephron; 1991; 58(1):119-20. PubMed ID: 1857471
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: All Citrates Are Not Created Equal!
    Jacobs R; Honore PM; Hendrickx I; Spapen HD
    Blood Purif; 2016; 42(3):219-20. PubMed ID: 27529346
    [No Abstract]   [Full Text] [Related]  

  • 14. Citrate for regional anticoagulation. Effects on blood PO2, ammonia, and aluminum.
    Suki WN; Bonuelous RD; Yocom S; Conlin CA; Crater JE; Silas LM; Wright JA; Kelly CA
    ASAIO Trans; 1988; 34(3):524-7. PubMed ID: 3196557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Artificial organs and thrombosis: hemodialysis].
    Matsui N
    Nihon Rinsho; 1986 May; 44(5):1211-17. PubMed ID: 3091886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)].
    Suzuki S; Tahara C; Kazama M
    Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protease inhibitors as anticoagulant in hemodialysis].
    Yamamoto H; Kawaguchi Y; Sakai O
    Nihon Rinsho; 1991 Dec; 49 Suppl():741-5. PubMed ID: 1808345
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months.
    Mehta RL; McDonald BR; Ward DM
    Contrib Nephrol; 1991; 93():210-4. PubMed ID: 1802583
    [No Abstract]   [Full Text] [Related]  

  • 19. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin versus citrate in the extracorporeal circuitry].
    Vertolli U
    G Ital Nefrol; 2007; 24(4):353; author reply 353-4. PubMed ID: 17659511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.